SUMMARY Although cystic fibrosis is noted primarily for pronounced abnormalities in pulmonary function, a substantial number of patients die as a result of cardiac complications. Nevertheless, little is known about cardiac performance in this disease. The cardiac pathophysiological consequences of cystic fibrosis were investigated non-invasively by measuring right and left ventricular performance using radionuclide angiocardiography. Studies were performed in 22 ambulatory young adults with cystic fibrosis and clinically evident pulmonary disease. Right ventricular ejection fraction was abnormal (<45%) in nine patients, while left ventricular ejection fraction was normal (>55%) in all 22 patients.
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Within one year of radionuclide evaluation, four patients with depressed baseline right ventricular function developed acute cor pulmonale and died. The presence ofabnormal right ventricular performance was related to the severity of cystic fibrosis. Arterial oxygen tension, forced expiratory volume in one second, and forced vital capacity were significantly less in patients with abnormal right ventricular ejection fraction than in those with normal function. All six patients with severe disease (Schwachman clinical score <40) had abnormal right ventricular ejection fraction, while none of 10 with good to excellent scores had abnormal right ventricular function. Radionuclide angiocardiography allows non-invasive detection of right ventricular dysfunction at a time when it would not be appreciated by conventional clinical methods. This approach provides pathophysiological insights into the haemodynamic abnormalities associated with this disease and may also allow the response to treatment to be monitored.
Cor pulmonale and respiratory failure are common in cystic fibrosis, particularly at the time of death. '-8 Unfortunately, right ventricular hypertrophy and right heart failure frequently are difficult to identify before overt cardiopulmonary decompensation.5 6 9-11 Because of a lack of accurate noninvasive techniques, the relation between the severity of cystic fibrosis and right and left ventricular performance has not been determined. In fact, relatively little is known about the early pathophysiological abnormalities in cardiac performance which commonly are undetected before the development of cor pulmonale. 44% ). All four patients with cor pulmonale subsequently died as a result of cardiorespiratory failure. Necropsy data were available in two patients (cases 1 and 4), and both had evidence of right ventricular hypertrophy and dilatation.6 23 The left ventricle was normal in both cases. No other patient in the study died within the follow-up period. Of the 22 patients in the study, only two patients (cases 4 and 6) had electrocardiographic evidence of right ventricular hypertrophy24 (right ventricular ejection fractions, 39 and 41%). At the time of data analysis, four patients (cases 3, 4, 9, and 11) have radionuclide evidence of right ventricular dysfunction but are clinically stable. None of these four patients or the 13 with normal right ventricular ejection fraction have signs or symptoms of cor pulmonale.
The presence of right ventricular dysfunction was related to the severity of cystic fibrosis as determined by the Schwachman clinical score. Right ventricular ejection fraction was 42 ±1 per cent (mean ± SEM) in patients with severe cystic fibrosis, compared with 49±3 per cent in those with mild to moderate clinical scores, and 56 ±2 per cent in those with good to excellent scores (p <0 001 for between group means) (Fig. 2) (Fig. 4) 
